Role of Selenium in Pathogenesis and Treatment of the Autoimmune Diseases
Keywords:
Selenium, Pathogenesis, Treatment, Autoimmune DiseasesAbstract
In vitro investigations have revealed that consumption of selenium can considerably decrease the expression of IFN-g in Th1 cells. A low plasma selenium content has been shown amongst cases with any of a variety of disorders, including autoimmune diseases, although neither the reason for this anomaly nor its possible functional importance are known. The seleno-enzyme glutathione peroxidase has role in the antioxidant defence by reacting with hydrogen peroxide and related compounds. Different oxygen radicals may have role in the pathogenesis of autoimmune disseases, and the accumulation of lipid peroxidation products in body fluids has been shown. In mammals, selenium is covalently bound commonly in selenocysteine moieties in proteins, and in human tissue glutathione peroxidase is the only selenoprotein hitherto found. In a previous investigation, most of the selenium in human plasma was shown to be located in selenoproteins other than glutathione peroxidase. Few other investigations on selenium localization in human tissue have been carried out, one reason probably being the difficulty in indicating the low selenium levels present in biological material.
References
Diroximel fumarate for multiple sclerosis. Aust Prescr. 2022;45(5):180.
Amin NS, Tayebi HME. More gain, less pain: How resistance training affects immune system functioning in multiple sclerosis patients: A review. Mult Scler Relat Disord. 2022;69:104401.
Arneth B, Kraus J. The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis. Medicina (Kaunas). 2022;58(11).
Bientinesi R, Gavi F, Coluzzi S, Nociti V, Marturano M, Sacco E. Neurologic Urinary Incontinence, Lower Urinary Tract Symptoms and Sexual Dysfunctions in Multiple Sclerosis: Expert Opinions Based on the Review of Current Evidences. J Clin Med. 2022;11(21).
Blagov AV, Sukhorukov VN, Orekhov AN, Sazonova MA, Melnichenko AA. Significance of Mitochondrial Dysfunction in the Progression of Multiple Sclerosis. Int J Mol Sci. 2022;23(21).
Brincks J, Dalgas U, Franzén E, Callesen J, Wallin A, Johansson S. Unwrapping the "black box" of balance training in people with multiple sclerosis - A descriptive systematic review of intervention components, progression, and intensity. Mult Scler Relat Disord. 2022;69:104412.
Castellano-Aguilera A, Biviá-Roig G, Cuenca-Martínez F, Suso-Martí L, Calatayud J, Blanco-Díaz M, et al. Effectiveness of Virtual Reality on Balance and Risk of Falls in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19(21).
Constantinescu V, Haase R, Akgün K, Ziemssen T. S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review. Ther Adv Neurol Disord. 2022;15:17562864221133163.
Correale J, Marrodan M. Multiple sclerosis and obesity: The role of adipokines. Front Immunol. 2022;13:1038393.
Costantini E, Masciarelli E, Casorri L, Di Luigi M, Reale M. Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk. Front Cell Neurosci. 2022;16:985943.
Diakou I, Papakonstantinou E, Papageorgiou L, Pierouli K, Dragoumani K, Spandidos DA, et al. Multiple sclerosis and computational biology (Review). Biomed Rep. 2022;17(6):96.
Dobson R, Rice DR, D'Hooghe M, Horne R, Learmonth Y, Mateen FJ, et al. Social determinants of health in multiple sclerosis. Nat Rev Neurol. 2022;18(12):723-34.
Dziedzic A, Saluk J. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment. Int J Mol Sci. 2022;23(22).
Fadda G, Flanagan EP, Cacciaguerra L, Jitprapaikulsan J, Solla P, Zara P, et al. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Front Neurol. 2022;13:1011579.
Filippi M, Preziosa P, Arnold DL, Barkhof F, Harrison DM, Maggi P, et al. Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective. J Neurol. 2022.
Freeman L, Longbrake EE, Coyle PK, Hendin B, Vollmer T. High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing-Remitting Multiple Sclerosis. CNS Drugs. 2022;36(12):1285-99.
Gharagozloo M, Mace JW, Calabresi PA. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Front Mol Neurosci. 2022;15:995477.
Ghasemi Darestani N, Bahrami A, Mozafarian MR, Esmalian Afyouni N, Akhavanfar R, Abouali R, et al. Association of Polyunsaturated Fatty Acid Intake on Inflammatory Gene Expression and Multiple Sclerosis: A Systematic Review and Meta-Analysis. Nutrients. 2022;14(21).
Hassani A, Khan G. What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis? Front Immunol. 2022;13:1036155.
Hauer L, Sellner J. Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data. Drug Des Devel Ther. 2022;16:3915-27.
Hoffman K, Brownell Z, Doyle WJ, Ochoa-Repáraz J. The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model. J Autoimmun. 2022:102957.
Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 2022.
Maciak K, Dziedzic A, Saluk J. Possible role of the NLRP3 inflammasome and the gut-brain axis in multiple sclerosis-related depression. Faseb j. 2023;37(1):e22687.
Melamed E, Palmer JL, Fonken C. Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis. Front Mol Neurosci. 2022;15:1019877.
Mendelsohn Z, Pemberton HG, Gray J, Goodkin O, Carrasco FP, Scheel M, et al. Commercial volumetric MRI reporting tools in multiple sclerosis: a systematic review of the evidence. Neuroradiology. 2022.
Mirmosayyeb O, Zivadinov R, Weinstock-Guttman B, Benedict RHB, Jakimovski D. Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis. J Neurol. 2022.
Pérez CA, Cuascut FX, Hutton GJ. Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update. Neurol Clin. 2023;41(1):87-106.
Pérez MMG, Eisele SJG. MicroRNAs as a possible biomarker in the treatment of multiple sclerosis. IBRO Neurosci Rep. 2022;13:492-9.
Pugliatti M, Hartung HP, Oreja-Guevara C, Pozzilli C, Airas L, Alkhawajah M, et al. Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in. Front Immunol. 2022;13:1045101.
Qu X, Walsh EI, Cherbuin N, Black LJ. Mapping the Literature on Diet and Multiple Sclerosis: A Data-Driven Approach. Nutrients. 2022;14(22).
Ramesh V, Opara CO, Khan FY, Kabiraj G, Kauser H, Palakeel JJ, et al. Adverse Obstetric Outcomes in Pregnant Women Using Natalizumab for the Treatment of Multiple Sclerosis: A Systematic Review. Cureus. 2022;14(10):e29952.
Razi O, Teixeira AM, Tartibian B, Zamani N, Knechtle B. Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise. Mol Cell Biochem. 2022:1-27.
Reder AT, Stuve O, Tankou SK, Leist TP. T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy. Mult Scler. 2022:13524585221134216.
Sedighi S, Gholizadeh O, Yasamineh S, Akbarzadeh S, Amini P, Favakehi P, et al. Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis. Curr Microbiol. 2022;80(1):15.
Shahi SK, Yadav M, Ghimire S, Mangalam AK. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics. Int Rev Neurobiol. 2022;167:185-215.
Simoens S. Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies. Front Neurol. 2022;13:1015256.
Simpson R, Posa S, Bruno T, Simpson S, Wasilewski MB, Robinson LR, et al. Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review. J Neurol. 2022.
Simpson R, Posa S, Langer L, Bruno T, Simpson S, Lawrence M, et al. A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis. J Neurol. 2022:1-20.
Sips FLP, Pappalardo F, Russo G, Bursi R. In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim. BMC Med Inform Decis Mak. 2022;22(Suppl 6):294.
Siracusano M, Carloni E, Riccioni A, Ferrara M, Scoppola C, Arturi L, et al. Maternal Multiple Sclerosis and Offspring's Cognitive and Behavioral Development: What Do We Know until Now? Children (Basel). 2022;9(11).
Solmaz İ, Öncel İ. Evolution of clinically isolated syndrome to pediatric-onset multiple sclerosis and a review of the literature. Turk J Med Sci. 2022;52(4):1281-7.
Theodosis-Nobelos P, Rekka EA. Efforts Towards Repurposing of Antioxidant Drugs and Active Compounds for Multiple Sclerosis Control. Neurochem Res. 2022.
Voskuhl RR, MacKenzie-Graham A. Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Front Mol Neurosci. 2022;15:1024058.
Vukusic S, Marignier R, Ciron J, Bourre B, Cohen M, Deschamps R, et al. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society. Mult Scler. 2022:13524585221130934.
Warutkar V, Gulrandhe P, Morghade S, Krishna Kovela R, Qureshi MI. Physiotherapy for Multiple Sclerosis Patients From Early to Transition Phase: A Scoping Review. Cureus. 2022;14(10):e30779.
Wills OC, Probst YC. Understanding lifestyle self-management regimens that improve the life quality of people living with multiple sclerosis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2022;20(1):153.
Xu D, Wang M. Research progress of statins on immune regulation of multiple sclerosis and experimental allergic encephalomyelitis. Allergol Immunopathol (Madr). 2022;50(6):76-83.
Zhang X, Huai Y, Wei Z, Yang W, Xie Q, Yi L. Non-invasive brain stimulation therapy on neurological symptoms in patients with multiple sclerosis: A network meta analysis. Front Neurol. 2022;13:1007702.
Zhou Q, Jia R, Dang J. Correlation between the Neutrophil-to-Lymphocyte Ratio and Multiple Sclerosis: Recent Understanding and Potential Application Perspectives. Neurol Res Int. 2022;2022:3265029.
Ziemssen T, Bhan V, Chataway J, Chitnis T, Campbell Cree BA, Havrdova EK, et al. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. Neurol Neuroimmunol Neuroinflamm. 2023;10(1).
Hesamian MS, Eskandari N. Potential Role of Trace Elements (Al, Cu, Zn, and Se) in Multiple Sclerosis Physiopathology. Neuroimmunomodulation. 2020;27(4):163-77.
Nirooei E, Kashani SMA, Owrangi S, Malekpour F, Niknam M, Moazzen F, et al. Blood Trace Element Status in Multiple Sclerosis: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2022;200(1):13-26.
Sanadgol N, Zahedani SS, Sharifzadeh M, Khalseh R, Barbari GR, Abdollahi M. Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis. Curr Drug Targets. 2017;18(13):1499-517.
Tanaka M, Vécsei L. Monitoring the Redox Status in Multiple Sclerosis. Biomedicines. 2020;8(10).
Zahir ST, Hesami M, Gharaeikhezri A, Rahmani K, Zare S, Shafiee M. The Evaluation of the recurrence and survival in patients with papillary thyroid cancer: A retrospective Study. Pakistan Journal of Medical and Health Sciences. 2021;15(3):1074-7.
Saberian P, Hesami M, Tavakoli N, Hasani-Sharamin P, Hatami ZA, Dadashi F, et al. At-risk COVID-19 Patients; Knowledge and Attitude of Those in Need of Transfer to Hospital and Consequences in Non-transferred Patients. Health Scope. 2022;11(1).
Zahir ST, Hesami M, Gharaeikhezri A, Ghasemi K, Rahmani K, Gharaeikhezri MH, et al. Molecular study in breast Paget’s disease and its relationship with the prognosis: A retrospective-analytical study. ACADEMIC JOURNAL.
Belal MH. Management of symptomatic erosive-ulcerative lesions of oral lichen planus in an adult Egyptian population using Selenium-ACE combined with topical corticosteroids plus antifungal agent. Contemp Clin Dent. 2015;6(4):454-60.
Qataya PO, Elsayed NM, Elguindy NM, Ahmed Hafiz M, Samy WM. Selenium: A sole treatment for erosive oral lichen planus (Randomized controlled clinical trial). Oral Dis. 2020;26(4):789-804.
Anitua E, Alkhraisat MH, Piñas L, Torre A, Eguia A. Implant-prosthetic treatment in patients with oral lichen planus: A systematic review. Spec Care Dentist. 2022;42(1):60-72.
da Silva EL, de Lima TB, Rados PV, Visioli F. Efficacy of topical non-steroidal immunomodulators in the treatment of oral lichen planus: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(9):5149-69.
De Porras-Carrique T, Ramos-García P, Aguilar-Diosdado M, Warnakulasuriya S, González-Moles M. Autoimmune disorders in oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2022.
Del Vecchio A, Palaia G, Grassotti B, Tenore G, Ciolfi C, Podda G, et al. Effects of laser photobiomodulation in the management of oral lichen planus: a literature review. Clin Ter. 2021;172(5):467-83.
Didona D, Caposiena Caro RD, Sequeira Santos AM, Solimani F, Hertl M. Therapeutic strategies for oral lichen planus: State of the art and new insights. Front Med (Lausanne). 2022;9:997190.
Didona D, Hertl M. Detection of anti-desmoglein antibodies in oral lichen planus: What do we know so far. Front Immunol. 2022;13:1001970.
El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2022.
Ghazi N, Khorasanchi M. Markers associated with malignant transformation of oral lichen planus: A review article. Arch Oral Biol. 2021;127:105158.
Gholizadeh N, Sheykhbahaei N. Micronutrients Profile in Oral Lichen Planus: a Review Literature. Biol Trace Elem Res. 2021;199(3):912-24.
González-Moles M, Keim-Del Pino C, Ramos-García P. Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses. Int J Mol Sci. 2022;23(21).
González-Moles M, Ramos-García P. Oral lichen planus and related lesions. What should we accept based on the available evidence? Oral Dis. 2022.
González-Moles M, Ramos-García P, Warnakulasuriya S. An appraisal of highest quality studies reporting malignant transformation of oral lichen planus based on a systematic review. Oral Dis. 2021;27(8):1908-18.
González-Moles M, Warnakulasuriya S, González-Ruiz I, Ayén Á, González-Ruiz L, Ruiz-Ávila I, et al. Dysplasia in oral lichen planus: relevance, controversies and challenges. A position paper. Med Oral Patol Oral Cir Bucal. 2021;26(4):e541-e8.
Górski B. Dental Implant Treatment in Patients Suffering from Oral Lichen Planus: A Narrative Review. Int J Environ Res Public Health. 2022;19(14).
Gururaj N, Hasinidevi P, Janani V, Divynadaniel T. Diagnosis and management of oral lichen planus - Review. J Oral Maxillofac Pathol. 2021;25(3):383-93.
Hamour AF, Klieb H, Eskander A. Oral lichen planus. Cmaj. 2020;192(31):E892.
Hazzaa HH, El Shiekh MAM, Abdelgawad N, Gouda OM, Kamal NM. Correlation of VEGF and MMP-2 levels in oral lichen planus: An in vivo immunohistochemical study. J Oral Biol Craniofac Res. 2020;10(4):747-52.
Hesse J, Schmalfuss A, Kvaal SI. Photodynamic therapy of oral lichen planus. Photochem Photobiol Sci. 2020;19(10):1271-9.
Husein-ElAhmed H, Steinhoff M. Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis. J Eur Acad Dermatol Venereol. 2022;36(10):1735-44.
Hussein H, Brown R. Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(1):e9-e13.
Jung W, Jang S. Oral Microbiome Research on Oral Lichen Planus: Current Findings and Perspectives. Biology (Basel). 2022;11(5).
Kalaskar AR, Bhowate RR, Kalaskar RR, Walde SR, Ramteke RD, Banode PP. Efficacy of Herbal Interventions in Oral Lichen Planus: A Systematic Review. Contemp Clin Dent. 2020;11(4):311-9.
Li K, He W, Hua H. Characteristics of the psychopathological status of oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2022;67(2):113-24.
Li W, Gao X, Wang Y, Xu Y, Zhang X, Chen J. Oral lichen planus induced by long-term use of antimicrobials for recurrent aphthous ulcer: A case report and literature review. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(6):666-72.
Li Y, He Y, Xiang J, Feng L, Wang Y, Chen R. The Functional Mechanism of MicroRNA in Oral Lichen Planus. J Inflamm Res. 2022;15:4261-74.
Lucchese A, Di Stasio D, Romano A, Fiori F, De Felice GP, Lajolo C, et al. Correlation between Oral Lichen Planus and Viral Infections Other Than HCV: A Systematic Review. J Clin Med. 2022;11(18).
Łukaszewska-Kuska M, Ślebioda Z, Dorocka-Bobkowska B. The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus- A systematic review. Oral Dis. 2022;28(8):2063-71.
Mallah N, Ignacio Varela-Centelles P, Seoane-Romero J, Takkouche B. Diabetes mellitus and oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2022;28(8):2100-9.
Manfredini M, Pedroni G, Bigi L, Apponi R, Murri Dello Diago A, Dattola A, et al. Acquired White Oral Lesions with Specific Patterns: Oral Lichen Planus and Lupus Erythematosus. Dermatol Pract Concept. 2021;11(3):e2021074.
Moosavi MS, Tavakol F. Literature review of cancer stem cells in oral lichen planus: a premalignant lesion. Stem Cell Investig. 2021;8:25.
Nunes GP, Pirovani BO, Nunes LP, Silva ANA, Morábito M, Nunes-Júnior NA, et al. Does oral lichen planus aggravate the state of periodontal disease? A systematic review and meta-analysis. Clin Oral Investig. 2022;26(4):3357-71.
Offen E, Allison JR. What is the malignant transformation potential of oral lichen planus? Evid Based Dent. 2022;23(1):36-7.
Osorio-Osorno YA, Parada-Sanchez MT, Arango JC, Arboleda Toro D. Oral lichen planus: A chronic inflammatory model to study the regulation of the Toll-like receptor signaling in oral keratinocytes. J Oral Biosci. 2020;62(2):115-22.
Rodriguez-Archilla A, Fernandez-Torralbo S. Candida species colonization in oral lichen planus: A meta-analysis. Int J Health Sci (Qassim). 2022;16(4):58-63.
Rotaru D, Chisnoiu R, Picos AM, Picos A, Chisnoiu A. Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med. 2020;20(6):198.
Rotaru DI, Sofineti D, Bolboacă SD, Bulboacă AE. Diagnostic Criteria of Oral Lichen Planus: A Narrative Review. Acta Clin Croat. 2020;59(3):513-22.
Saeed S, Choudhury P, Ahmad SA, Alam T, Panigrahi R, Aziz S, et al. Vitamin D in the Treatment of Oral Lichen Planus: A Systematic Review. Biomedicines. 2022;10(11).
Sahoo A, Jena AK, Panda M. Experimental and clinical trial investigations of phyto-extracts, phyto-chemicals and phyto-formulations against oral lichen planus: A systematic review. J Ethnopharmacol. 2022;298:115591.
Seif S, Afra N, Dadgar E, Enteghad S, Argani P, Aghdasi N, et al. The expression of salivary microRNAs in oral lichen planus: Searching for a prognostic biomarker. Pathol Res Pract. 2022;234:153923.
Shang Q, Peng J, Zhou Y, Chen Q, Xu H. Association of Human Papillomavirus With Oral Lichen Planus and Oral Leukoplakia: A Meta-analysis. J Evid Based Dent Pract. 2020;20(4):101485.
Shikha, Gupta S, Mahajan A, Ambika, Garg R, Ghosh S. Childhood oral lichen planus: a case series with review of literature. Eur Arch Paediatr Dent. 2022;23(2):341-53.
Ślebioda Z, Dorocka-Bobkowska B. Low-level laser therapy in the treatment of recurrent aphthous stomatitis and oral lichen planus: a literature review. Postepy Dermatol Alergol. 2020;37(4):475-81.
Su Z, Hu J, Cheng B, Tao X. Efficacy and safety of topical administration of tacrolimus in oral lichen planus: An updated systematic review and meta-analysis of randomized controlled trials. J Oral Pathol Med. 2022;51(1):63-73.
Torrejon-Moya A, Saka-Herrán C, Izquierdo-Gómez K, Marí-Roig A, Estrugo-Devesa A, López-López J. Oral Lichen Planus and Dental Implants: Protocol and Systematic Review. J Clin Med. 2020;9(12).
Vadivel JK, Ezhilarasan D, Govindarajan M, Somasundaram E. Therapeutic effectiveness of alternative medications in oral lichen planus: A systematic review. J Oral Maxillofac Pathol. 2020;24(2):344-51.
Vijayan AK, Muthukrishnan A, Vidyadharan M, Nair AM. Role of Human Papilloma Virus in Malignant Transformation of Oral Lichen Planus: A Systematic Review. J Pharm Bioallied Sci. 2021;13(Suppl 1):S62-s7.
Villa TG, Sánchez-Pérez Á, Sieiro C. Oral lichen planus: a microbiologist point of view. Int Microbiol. 2021;24(3):275-89.
Waingade M, Medikeri RS, Rathod P. Effectiveness of methylene blue photosensitizers compared to that of corticosteroids in the management of oral lichen planus: a systematic review and meta-analysis. J Dent Anesth Pain Med. 2022;22(3):175-86.
Wang R, Zhang X, Wang S. Differential genotypes of TNF-α and IL-10 for immunological diagnosis in discoid lupus erythematosus and oral lichen planus: A narrative review. Front Immunol. 2022;13:967281.
Xia DN, Tan YQ, Yang JY, Zhou G. Omega-3 polyunsaturated fatty acids: a promising approach for the management of oral lichen planus. Inflamm Res. 2020;69(10):989-99.
Xie F, Meves A, Lehman JS. The genomic and proteomic landscape in oral lichen planus versus oral squamous cell carcinoma: a scoping review. Int J Dermatol. 2022;61(10):1227-36.
Yuwanati M, Gondivkar S, Sarode SC, Gadbail A, Sarode GS, Patil S, et al. Impact of Oral Lichen Planus on Oral Health-Related Quality of Life: A Systematic Review and Meta-Analysis. Clin Pract. 2021;11(2):272-86.
Zanetta P, Ormelli M, Amoruso A, Pane M, Azzimonti B, Squarzanti DF. Probiotics as Potential Biological Immunomodulators in the Management of Oral Lichen Planus: What's New? Int J Mol Sci. 2022;23(7).
Bimekizumab for plaque psoriasis. Aust Prescr. 2022;45(4):132-3.
Andújar I, Esplugues JV, García-Martínez P. Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics. Pharmaceuticals (Basel). 2022;15(9).
Bartholomew E, Chung M, Yeroushalmi S, Hakimi M, Bhutani T, Liao W. Mindfulness and Meditation for Psoriasis: A Systematic Review. Dermatol Ther (Heidelb). 2022;12(10):2273-83.
Bellinato F, Chiricozzi A, Piaserico S, Targher G, Gisondi P. Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? Int J Mol Sci. 2022;23(21).
Boswell ND, Cook MK, Balogh EA, Feldman SR. The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature review. Arch Dermatol Res. 2022.
Chat VS, Kearns DG, Uppal SK, Han G, Wu JJ. Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice. Cutis. 2022;110(2 Suppl):8-14.
Controne I, Scoditti E, Buja A, Pacifico A, Kridin K, Fabbro MD, et al. Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review. Nutrients. 2022;14(20).
Dhabale A, Nagpure S. Types of Psoriasis and Their Effects on the Immune System. Cureus. 2022;14(9):e29536.
Diotallevi F, Simonetti O, Rizzetto G, Molinelli E, Radi G, Offidani A. Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives. Int J Mol Sci. 2022;23(19).
Drakos A, Vender R. A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians. Dermatol Ther (Heidelb). 2022;12(12):2715-30.
Ehsan M, Rehman AU, Athar F, Mustafa B, Javed H, Cheema HA, et al. Benvitimod for the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials. Dermatol Ther. 2022:e15957.
Estevinho T, Lé AM, Torres T. Deucravacitinib in the treatment of psoriasis. J Dermatolog Treat. 2022:1-22.
Feng Y, Zhou B, Wang Z, Xu G, Wang L, Zhang T, et al. Risk of Candida Infection and Serious Infections in Patients with Moderate-to-Severe Psoriasis Receiving Biologics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Clin Pract. 2022;2022:2442603.
Frątczak A, Polak K, Szczepanek M, Lis-Święty A. The role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in the pathophysiology of psoriasis and systemic lupus erythematosus. Postepy Dermatol Alergol. 2022;39(4):645-50.
Gautam P, Maenner S, Cailotto F, Reboul P, Labialle S, Jouzeau JY, et al. Emerging role of IκBζ in inflammation: Emphasis on psoriasis. Clin Transl Med. 2022;12(10):e1032.
Golhen K, Winskill C, Theiler M, Buettcher M, Yeh YH, Zhang N, et al. Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis. Front Med (Lausanne). 2022;9:944208.
Gupta A, Madke B. Psoriasis a Cause of Cardiovascular Diseases: A Review Article. Cureus. 2022;14(8):e27767.
Jensen NC, Robins J, Snyder AM, Harris R, Ferris LK, Johnson L. Psoriasis in the transplant population. Arch Dermatol Res. 2022.
Kašnar AM, Jurić K, Franić A, Čeović R. Current Knowledge on Psoriasis During the Covid-19 Pandemic. Acta Dermatovenerol Croat. 2022;30(2):99-105.
Kim J, Moreno A, Krueger JG. The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris. Front Immunol. 2022;13:1005115.
Kudish AI, Evseev EG, Cohen G, Harari M. Ultraviolet Measurements and Photoclimatotherapy for Psoriasis at the Dead Sea: 25 Years of Experience. Int J Environ Res Public Health. 2022;19(19).
Kurpet K, Chwatko G. S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases. Molecules. 2022;27(19).
Lin CP, Merola JF, Wallace EB. Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis. Curr Opin Pharmacol. 2022;67:102292.
Makuch S, Dróżdż M, Makarec A, Ziółkowski P, Woźniak M. An Update on Photodynamic Therapy of Psoriasis-Current Strategies and Nanotechnology as a Future Perspective. Int J Mol Sci. 2022;23(17).
Nabieva K, Vender R. Quality of Life and Body Region Affected by Psoriasis: A Systematic Review. Actas Dermosifiliogr. 2022.
Nijakowski K, Gruszczyński D, Kolasińska J, Kopała D, Surdacka A. Periodontal Disease in Patients with Psoriasis: A Systematic Review. Int J Environ Res Public Health. 2022;19(18).
Nogueira S, Rodrigues MA, Vender R, Torres T. Tapinarof for the treatment of psoriasis. Dermatol Ther. 2022:e15931.
Nowowiejska J, Baran A, Flisiak I. Psoriasis and neurodegenerative diseases-a review. Front Mol Neurosci. 2022;15:917751.
Nowowiejska J, Baran A, Flisiak I. Fatty Acid-Binding Proteins in Psoriasis-A Review. Metabolites. 2022;12(9).
Olszewski R, Ćwiklińska K, Maślińska M, Kwiatkowska B. Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis. Reumatologia. 2022;60(4):266-74.
Pandey P, Kumar S. Effectiveness of Dialysis in Psoriasis: A Short Review. Cureus. 2022;14(10):e30061.
Panieri E, Telkoparan-Akillilar P, Saso L. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. Biofactors. 2022.
Parab S, Doshi G. An update on emerging immunological targets and their inhibitors in the treatment of psoriasis. Int Immunopharmacol. 2022;113(Pt A):109341.
Pixley JN, Schaetzle T, Feldman SR. A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis. Ann Pharmacother. 2022:10600280221137750.
Prinz JC, Choon SE, Griffiths CEM, Merola JF, Morita A, Ashcroft DM, et al. Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. J Eur Acad Dermatol Venereol. 2022.
Reynolds KA, Pithadia DJ, Lee EB, Clarey D, Liao W, Wu JJ. Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment. Cutis. 2022;110(2 Suppl):19-25.
Ruda RC, Kelly KA, Feldman SR. Real-World Outcomes Following Switching from Anti-TNF Reference Products to Biosimilars for the Treatment of Psoriasis. J Dermatolog Treat. 2022:1-29.
Ruggiero A, Megna M, Fabbrocini G, Fornaro L, Villani A. Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge. Expert Opin Drug Saf. 2022;21(10):1249-57.
Shang L, Cao J, Zhao S, Zhang J, He Y. TYK2 in Immune Responses and Treatment of Psoriasis. J Inflamm Res. 2022;15:5373-85.
Shi L, Liu C, Xiong H, Shi D. Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon? Front Med (Lausanne). 2022;9:1007892.
Simard M, Morin S, Ridha Z, Pouliot R. Current knowledge of the implication of lipid mediators in psoriasis. Front Immunol. 2022;13:961107.
Sobolev VV, Tchepourina E, Korsunskaya IM, Geppe NA, Chebysheva SN, Soboleva AG, et al. The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells. Int J Mol Sci. 2022;23(17).
Strouphauer E, Stolar A, Tollefson M. Manifestation of anxiety and depression among pediatric patients with psoriasis: A review. Pediatr Dermatol. 2022.
Strychalski ML, Brown HS, Bishop SC. Cytokine Modulators in Plaque Psoriasis - A Review of Current and Prospective Biologic Therapeutic Approaches. JAAD Int. 2022;9:82-91.
Vu A, Maloney V, Gordon KB. Deucravacitinib in moderate-to-severe psoriasis. Immunotherapy. 2022;14(16):1279-90.
Wang J, Gao J, Huang C, Jeong S, Ko R, Shen X, et al. Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis. Front Genet. 2022;13:929162.
Wroński A, Wójcik P. Impact of ROS-Dependent Lipid Metabolism on Psoriasis Pathophysiology. Int J Mol Sci. 2022;23(20).
Yadav G, Yeung J, Miller-Monthrope Y, Lakhani O, Drudge C, Craigie S, et al. Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States. Dermatol Ther (Heidelb). 2022;12(11):2401-13.
Yang XY, Cai WL, Guo CL, Chen QH. Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future. Chin J Integr Med. 2022.
Young PA, Su MW, Inkeles MS, Kiuru M, Fung MA, Kuo WE. IgA Vasculitis in the Setting of Biologic Therapy for Psoriasis and Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus Colonization. Cutis. 2022;110(4):E4-e10.
Yu J, Zhao Q, Wang X, Zhou H, Hu J, Gu L, et al. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133:102916.
Zanesco S, Hall W, Gibson R, Griffiths C, Maruthappu T. Approaches to nutrition intervention in plaque psoriasis, a multi-system inflammatory disease-The Diet and Psoriasis Project (DIEPP). Nutr Bull. 2022;47(4):524-37.
Zhang L, Wang Y, Qiu L, Wu J. Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis. BMC Med. 2022;20(1):421.
Zhou Q, Yang L, Li T, Wang K, Huang X, Shi J, et al. Mechanisms and inhibitors of ferroptosis in psoriasis. Front Mol Biosci. 2022;9:1019447.
Zhou XY, Chen K, Zhang JA. Mast cells as important regulators in the development of psoriasis. Front Immunol. 2022;13:1022986.
Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C selenium; zinc; iron. World Rev Nutr Diet. 1988;55:165-82.
Chodorowska G, Kwiatek J. Psoriasis and cigarette smoking. Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):535-8.
Garbicz J, Całyniuk B, Górski M, Buczkowska M, Piecuch M, Kulik A, et al. Nutritional Therapy in Persons Suffering from Psoriasis. Nutrients. 2021;14(1).
Kanda N, Hoashi T, Saeki H. Nutrition and Psoriasis. Int J Mol Sci. 2020;21(15).
Kocic H, Damiani G, Stamenkovic B, Tirant M, Jovic A, Tiodorovic D, et al. Dietary compounds as potential modulators of microRNA expression in psoriasis. Ther Adv Chronic Dis. 2019;10:2040622319864805.
Millsop JW, Bhatia BK, Debbaneh M, Koo J, Liao W. Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol. 2014;71(3):561-9.
Murzaku EC, Bronsnick T, Rao BK. Diet in dermatology: Part II. Melanoma, chronic urticaria, and psoriasis. J Am Acad Dermatol. 2014;71(6):1053.e1-.e16.
Nazıroğlu M, Yıldız K, Tamtürk B, Erturan İ, Flores-Arce M. Selenium and psoriasis. Biol Trace Elem Res. 2012;150(1-3):3-9.
Pona A, Haidari W, Kolli SS, Feldman SR. Diet and psoriasis. Dermatol Online J. 2019;25(2).
Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin Dermatol. 2010;28(6):615-26.
Talbott W, Duffy N. Complementary and alternative medicine for psoriasis: what the dermatologist needs to know. Am J Clin Dermatol. 2015;16(3):147-65.
Rheumatoid arthritis and selenium. Nutr Rev. 1988;46(8):284-6.
Aaseth J, Haugen M, Førre O. Rheumatoid arthritis and metal compounds--perspectives on the role of oxygen radical detoxification. Analyst. 1998;123(1):3-6.
Darlington LG, Ramsey NW. Review of dietary therapy for rheumatoid arthritis. Br J Rheumatol. 1993;32(6):507-14.
Darlington LG, Ramsey NW. Review of dietary therapy for rheumatoid arthritis. Compr Ther. 1994;20(9):490-4.
Darlington LG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr. 2001;85(3):251-69.
Qamar N, John P, Bhatti A. Emerging role of selenium in treatment of rheumatoid arthritis: An insight on its antioxidant properties. J Trace Elem Med Biol. 2021;66:126737.
Rehman A, John P, Bhatti A. Biogenic Selenium Nanoparticles: Potential Solution to Oxidative Stress Mediated Inflammation in Rheumatoid Arthritis and Associated Complications. Nanomaterials (Basel). 2021;11(8).
Tarp U. Selenium and the selenium-dependent glutathione peroxidase in rheumatoid arthritis. Dan Med Bull. 1994;41(3):264-74.
Tarp U. Selenium in rheumatoid arthritis. A review. Analyst. 1995;120(3):877-81.
Turrubiates-Hernández FJ, Márquez-Sandoval YF, González-Estevez G, Reyes-Castillo Z, Muñoz-Valle JF. The Relevance of Selenium Status in Rheumatoid Arthritis. Nutrients. 2020;12(10).
Bäcklund R, Drake I, Bergström U, Compagno M, Sonestedt E, Turesson C. Diet and the risk of rheumatoid arthritis - A systematic literature review. Semin Arthritis Rheum. 2022;58:152118.
Badillo-Mata JA, Camacho-Villegas TA, Lugo-Fabres PH. 3D Cell Culture as Tools to Characterize Rheumatoid Arthritis Signaling and Development of New Treatments. Cells. 2022;11(21).
Ben Tekaya A, Mehmli T, Ben Sassi M, Teyeb Z, Bouden S, Rouached L, et al. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2022.
Bergstra SA, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards CJ, et al. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2022.
Ciofoaia EI, Pillarisetty A, Constantinescu F. Health disparities in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2022;14:1759720x221137127.
Desai N, Federico L, Baker JF. Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis. Rheum Dis Clin North Am. 2022;48(4):799-811.
Falcon RMG, Alcazar RMU, Mondragon AV, Penserga EG, Tantengco OAG. Rheumatoid arthritis and the risk of preterm birth. Am J Reprod Immunol. 2022.
Frazzei G, Musters A, de Vries N, Tas SW, van Vollenhoven RF. Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals. Autoimmun Rev. 2022:103217.
Gao A, Zhao W, Wu R, Su R, Jin R, Luo J, et al. Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis. J Autoimmun. 2022;133:102950.
Gao Y, Cai W, Zhou Y, Li Y, Cheng J, Wei F. Immunosenescence of T cells: a key player in rheumatoid arthritis. Inflamm Res. 2022;71(12):1449-62.
Giachi A, Cugno M, Gualtierotti R. Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis. Front Cardiovasc Med. 2022;9:1012661.
Inciarte-Mundo J, Frade-Sosa B, Sanmartí R. From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis. Front Immunol. 2022;13:1001025.
Ionescu CE, Popescu CC, Agache M, Dinache G, Codreanu C. Depression in Rheumatoid Arthritis: A Narrative Review-Diagnostic Challenges, Pathogenic Mechanisms and Effects. Medicina (Kaunas). 2022;58(11).
Jin S, Zhao J, Li M, Zeng X. New insights into the pathogenesis and management of rheumatoid arthritis. Chronic Dis Transl Med. 2022;8(4):256-63.
Khoshroo A, Ramezani K, Moghimi N, Bonakdar M, Ramezani N. The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients. Inflammopharmacology. 2022.
Li RL, Duan HX, Liang Q, Huang YL, Wang LY, Zhang Q, et al. Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis. Front Immunol. 2022;13:1046810.
Li Z, Wang J, Lin Y, Fang J, Xie K, Guan Z, et al. Newly discovered circRNAs in rheumatoid arthritis, with special emphasis on functional roles in inflammatory immunity. Front Pharmacol. 2022;13:983744.
Liang HY, Yin HX, Li SF, Chen Y, Zhao YJ, Hu W, et al. Calcium-Permeable Channels Cooperation for Rheumatoid Arthritis: Therapeutic Opportunities. Biomolecules. 2022;12(10).
Lu Q, Xu J, Jiang H, Wei Q, Huang R, Huang G. The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment. Front Pharmacol. 2022;13:1000865.
Luedders BA, Mikuls TR, Thiele GM, Poole JA, England BR. Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis. Rheum Dis Clin North Am. 2022;48(4):781-98.
Mane RR, Kale PP. The roles of HDAC with IMPDH and mTOR with JAK as future targets in the treatment of rheumatoid arthritis with combination therapy. J Complement Integr Med. 2022.
Opoku YK, Asare KK, Ghartey-Quansah G, Afrifa J, Bentsi-Enchill F, Ofori EG, et al. Intestinal microbiome-rheumatoid arthritis crosstalk: The therapeutic role of probiotics. Front Microbiol. 2022;13:996031.
Pankowski D, Wytrychiewicz-Pankowska K, Janowski K, Pisula E. The relationship between primary cognitive appraisals, illness beliefs, and adaptation to rheumatoid arthritis: A systematic review and meta-analysis. J Psychosom Res. 2022;164:111074.
Pathade V, Nene S, Ratnam S, Khatri DK, Raghuvanshi RS, Singh SB, et al. Emerging insights of peptide-based nanotherapeutics for effective management of rheumatoid arthritis. Life Sci. 2022:121257.
Peyronnel C, Totoson P, Martin H, Demougeot C. Relevance of circulating markers of endothelial activation for cardiovascular risk assessment in rheumatoid arthritis: A narrative review. Life Sci. 2022:121264.
Santos-Moreno P, Rodríguez-Vargas GS, Martínez S, Ibatá L, Rojas-Villarraga A. Metabolic Abnormalities, Cardiovascular Disease, and Metabolic Syndrome in Adult Rheumatoid Arthritis Patients: Current Perspectives and Clinical Implications. Open Access Rheumatol. 2022;14:255-67.
Sepriano A, Kerschbaumer A, Bergstra SA, Smolen JS, van der Heijde D, Caporali R, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2022.
Siempis T, Tsakiris C, Anastasia Z, Alexiou GA, Voulgaris S, Argyropoulou MI. Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis. Rheumatol Int. 2022.
Singh A, Behl T, Sehgal A, Singh S, Sharma N, Naqwi M, et al. Exploring the role of exosomes in rheumatoid arthritis. Inflammopharmacology. 2022.
Slagter L, Demyttenaere K, Verschueren P, De Cock D. The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis. J Pers Med. 2022;12(11).
Torres A, Pedersen B, Guma M. Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes. Front Immunol. 2022;13:984408.
Wang S, Zhou Y, Huang J, Li H, Pang H, Niu D, et al. Advances in experimental models of rheumatoid arthritis. Eur J Immunol. 2022.
Watanabe R, Okano T, Gon T, Yoshida N, Fukumoto K, Yamada S, et al. Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems. Front Med (Lausanne). 2022;9:1049875.
Winthrop K, Isaacs J, Calabrese L, Mittal D, Desai S, Barry J, et al. Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review. Semin Arthritis Rheum. 2022;58:152120.
Yang J, Li Z, Wang L, Yun X, Zeng Y, Ng JPL, et al. The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis. Pharmacol Res. 2022;186:106549.
Yi J, Liu Y, Xie H, An H, Li C, Wang X, et al. Hydrogels for the treatment of rheumatoid arthritis. Front Bioeng Biotechnol. 2022;10:1014543.
Zhang LB, Yan Y, He J, Wang PP, Chen X, Lan TY, et al. Epimedii Herba: An ancient Chinese herbal medicine in the prevention and treatment of rheumatoid arthritis. Front Chem. 2022;10:1023779.
Zhang X, Zhang X, Yang Y, Zhi K, Chen Y, Zhao J, et al. Association between passive smoking and the risk of rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2022.
Zinellu A, Mangoni AA. Platelet and Red Blood Cell Volume Indices in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022;12(11).
Ahmed Ali U, Kiran RP. Surgery for Crohn's disease: upfront or last resort? Gastroenterol Rep (Oxf). 2022;10:goac063.
Badla O, Goit R, Saddik SE, Dawood S, Rabih AM, Mohammed A, et al. The Multidisciplinary Management of Perianal Fistulas in Crohn's Disease: A Systematic Review. Cureus. 2022;14(9):e29347.
Bohra A, Vasudevan A, Kutaiba N, Van Langenberg DR. Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease. Diagnostics (Basel). 2022;12(10).
Choi D, Sheridan H, Bhat S. Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease. Ann Pharmacother. 2022:10600280221130450.
Chowdhury R, Kane SV. Pregnancy and Crohn's disease: concerns and assurance of medical therapy. Gastroenterol Rep (Oxf). 2022;10:goac055.
Esaki M, Sakata Y. Clinical Impact of Endoscopic Evaluation of the Small Bowel in Crohn's Disease. Digestion. 2022:1-7.
Freund MR, Emile SH, Horesh N, Garoufalia Z, Gefen R, Perets M, et al. Redo ileocolic resection for recurrent Crohn's disease: A review and meta-analysis of surgical outcomes. Surgery. 2022;172(6):1614-21.
Grassi G, Laino ME, Fantini MC, Argiolas GM, Cherchi MV, Nicola R, et al. Advanced imaging and Crohn's disease: An overview of clinical application and the added value of artificial intelligence. Eur J Radiol. 2022;157:110551.
Hanzel J, Drobne D. Contemporary Management of Postoperative Crohn's Disease after Ileocolonic Resection. J Clin Med. 2022;11(22).
Herman RB, Dumnicka P, Fyderek K. A review of magnetic resonance enterography based Crohn's disease activity indices in paediatric patients. Prz Gastroenterol. 2022;17(3):190-5.
Koh SJ, Hong SN, Park SK, Ye BD, Kim KO, Shin JE, et al. Korean clinical practice guidelines on biologics for moderate to severe Crohn's disease. Intest Res. 2022.
Lan N, Shen B. Endoscopic Therapy for Fistulas and Abscesses in Crohn's Disease. Gastrointest Endosc Clin N Am. 2022;32(4):733-46.
Lee DI, You MW, Park SH, Seo M, Park SJ. Comparison of Diagnostic Performance of Ultrasonography and Magnetic Resonance Enterography in the Assessment of Active Bowel Lesions in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022;12(8).
Lee KE, Cantrell S, Shen B, Faye AS. Post-operative prevention and monitoring of Crohn's disease recurrence. Gastroenterol Rep (Oxf). 2022;10:goac070.
Lukas M. Porcine Model of Anastomotic Stricture in Crohn's Disease. Gastrointest Endosc Clin N Am. 2022;32(4):719-31.
Odeyinka O, Alhashimi R, Thoota S, Ashok T, Palyam V, Azam AT, et al. The Role of Capsule Endoscopy in Crohn's Disease: A Review. Cureus. 2022;14(7):e27242.
Okai N, Watanabe T, Minaga K, Kamata K, Honjo H, Kudo M. Alterations of autophagic and innate immune responses by the Crohn's disease-associated ATG16L1 mutation. World J Gastroenterol. 2022;28(26):3063-70.
Puca P, Del Vecchio LE, Ainora ME, Gasbarrini A, Scaldaferri F, Zocco MA. Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn's Disease. Diagnostics (Basel). 2022;12(8).
Reider S, Binder L, Fürst S, Hatzl S, Blesl A. Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered? Cells. 2022;11(21).
Sleiman J, Chirra P, Gandhi NS, Baker ME, Lu C, Gordon IO, et al. Crohn's disease related strictures in cross-sectional imaging: More than meets the eye? United European Gastroenterol J. 2022.
Vincenzi P, Gaudenzi D, Mulazzani L, Rebonato A, Patriti A. Crohn's Disease and Jejunal Artery Aneurysms: A Report of the First Case and a Review of the Literature. Medicina (Kaunas). 2022;58(10).
Vlăsceanu S, Bobocea A, Petreanu CA, Bădărău IA, Moldovan H, Gheorghiță D, et al. Pulmonary Crohn's Disease or Crohn's Disease with Lung Sarcoidosis? A Case Report and Literature Review. Healthcare (Basel). 2022;10(11).
Wu PJ, Sun CS, Kuo HT, Sheu MJ, Lin CY, Wang SH, et al. Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term use of immunomodulators: a case report and review of the literature. J Med Case Rep. 2022;16(1):424.
Yamamoto H, Yano T, Araki A, Esaki M, Ohtsuka K, Ohmiya N, et al. Guidelines for endoscopic balloon dilation in treating Crohn's disease-associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy). Dig Endosc. 2022;34(7):1278-96.
Harries AD, Heatley RV. Nutritional disturbances in Crohn's disease. Postgrad Med J. 1983;59(697):690-7.
Duntas LH. The Role of Iodine and Selenium in Autoimmune Thyroiditis. Horm Metab Res. 2015;47(10):721-6.
Ahadiat S-A, Barati R, Moghadam NS, Samami E, Ghiabi S, Alyari M, et al. Role of Oxidative Stress and Antioxidants in Malignancies. Kindle. 2022;2(1):1-122.
Fard AM, Nikbakht T, Babaei N, Pouyamanesh M, Afzalian A, Kharazmkia A, et al. Role of Medicinal Plants in Treatment of Inflammatory Diseases. Kindle. 2022;2(1):1-139.
Ahadiat S-A, Falaverjani HG, Shabani M, Abadi SAH, Moazamiyanfar R, Rajabi SK, et al. The Role of Stem Cells in Treatment of Autoimmune Diseases. Kindle. 2022;2(1):1-136.
Tabatabaei SOH, Moazamiyanfar R, Fard AM, Salemi MH, Masjedi MNK, Yazdani Y, et al. The Role of Melatonin in Pathogenesis and Treatment of Autoimmune Diseases. Kindle. 2022;2(1):1-126.
Ahadiat S-A, Atighi J, Forouhi M, Mashatan N, Ghahremaniyeh Z, Radmanesh M, et al. Diagnosis and Management of Complications of COVID-19. Kindle. 2022;2(1):1-113.
Ahadiat S-A, Ghazalgoo A, Abadi SAH, Falaverjani HG, Bagherianlemraski M, Namazifar F, et al. Role of Vitamin D in Pathogenesis, Diagnosis, and Treatment of Inflammatory Diseases. Kindle. 2022;2(1):1-119.
Abadi SAH, Atbaei R, Falaverjani HG, Forouhi M, Moazamiyanfar R, Rezaei M, et al. Preventive and Therapeutic Approaches in Medical Departments During the COVID-19 Pandemic. Kindle. 2022;2(1):1-216.
Ahadiat S-A, Shirazinia M, Shirazinia S, Garousi S, Mottahedi M, Jalali AB, et al. Role of Telemedicine in Management of Patients During the COVID-19 Pandemic. Kindle. 2022;2(1):1-191.
Yarmohammadi B, Rigi A, Sahebkar F, Ahadiat S-A, Gharei F, Heydarian P, et al. Guidelines for Providing Services in Medical Departments During the COVID-19 Pandemic. Kindle. 2022;2(1):1-193.
Farrokhi M, Vafaei S, Bidares M, Siami H, Rigi A, Hannaniyan M, et al. Diagnosis and Treatment of Manifestations of COVID-19. Kindle. 2021;1(1):1-170.
Farrokhi M, Rigi A, Mangouri A, Fadaei M, Shabani E, Mashouf P, et al. Role of Antioxidants in Autoimmune Diseases. Kindle. 2021;1(1):1-107.
Manavi SP, Amiri T, Mozafaryan MJ. Role of Flavonoids in Diabetes. Journal of Reviews in Medical Sciences. 2021;1(3):149-61.
Embry M, Simmons B. Clinical Manifestations and Characterization of COVID-19. Journal of Reviews in Medical Sciences. 2021;1(3):222-41.
Fisher RS, Liu J. Role of Telemedicine in Management of Patients During the COVID-19 Pandemic. Journal of Reviews in Medical Sciences. 2021;1(3):242-63.
